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Abstract 
Purpose: We aimed to evaluate the effect of obesity on surgical outcomes of mini percutaneous nephrolithotomy 
(Mini-PNL).
Methods: Hundred and eighty two Mini-PNL procedures were performed between May 2013 and January 2015 and 
their results were evaluated retrospectively. Patients were classified as non-obese (BMI, 18.5–30 kg/m2) and obese 
(≥30 kg/m2) groups. Obese and non-obese patients were compared according to pre-operative demographic values, 
intra-operative surgery techniques and post-operative results.
Results: BMI values of 133 patients were lower than 30 kg/m2 while 49 patient’s BMI values were higher than 30 kg/
m2. There were no significant difference between operation time, fluoroscopy time, number of access and access sites 
when two groups were compared. No significant difference was found in total length of hospital stay, hemoglobin 
drop, and complication rates. Stone-free rates were 70.7 % in the non-obese and 71.4 % in the obese group (p = 0.9).
Conclusions: Mini-PNL procedure is a safe and effective treatment modality, which should be strongly considered 
for obese patients with appropriate sized stones.
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Background
Obesity is a serious health problem that arises due to 
world’s changing social and economic status and physical 
inactivity (Shikora 2005). Obese patients have increased 
risk of having diseases like; diabetes mellitus, hyperten-
sion, cardiovascular diseases, obstructive sleep apnea 
syndrome, and urinary stone disease (Taylor et al. 2005; 
Stamatelou et  al. 2003; Curhan et  al. 1998). Increased 
insulin resistance, hyperinsulinemia, hypocitraturia, 
hyperoxaluria and hypercalcemia can be listed as possi-
ble causes of increased incidence of stone disease among 
obese patients (Goldfarb 2003; Yang and Bellman 2004; 
Curhan 2007). Thus, treatment of stone disease in obese 
patients may be more important health issue in the near 
future.
Shock wave lithotripsy (SWL) treatment in obese patients 
appears to be less effective due to increased skin-to-stone 
distance and difficulties in performing the procedure 
(Thomas and Cass 1993; Al-Hayek et al. 2013). Performing 
flexible URS (F-URS) in obese patients with high stone bur-
den can result in increased amount of residual stone frag-
ments (Fabrizio et al. 1998). Residual stone fragments may 
be an obstacle to optimal treatment of obese patients who 
have increased risk of having stone disease.
Percutaneous nephrolithotomy is a commonly per-
formed procedure in obese patients, even though it has 
certain problems like; bleeding, pain, and difficulties in 
positioning of the patient. Although several studies indi-
cate that PNL is a reasonable option in obese patients 
(Faerber and Goh 1997; Carson et  al. 1988; El-Assmy 
et al. 2007; Koo et al. 2004), there are also studies, which 
show increased risk of bleeding, technical difficulties in 
patient positioning, and difficulties in surgery techniques 
(Bagrodia et  al. 2008; Desai et  al. 2004; Sergeyev et  al. 
2007; Olbert et al. 2007).
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Bleeding which requires transfusion due to conven-
tional PNL procedure is one of the serious problems that 
urologists encounter. Transfusion rates can be as high 
as 21  % in morbid obese patients (Pearle et  al. 1998). 
According to one study, tract dilatation technique and 
diameter of the tract are listed as factors that affect the 
risk of bleeding (Kukreja et  al. 2004). After the inven-
tion of mini-PNL, the size of working sheaths decreased. 
This process resulted in decreased hemorrhage-related 
complications and hospitalization times with similar 
stone-free rates. Due to these reasons; mini-PNL proce-
dure, which is performed through a narrower and shorter 
tract, is preferred in appropriate cases (Helal et al. 1997). 
Today, with the development of different size instruments 
there is a confusion of terminology used to describe the 
procedures. However conventional PNL is done through 
the tract size >24 Fr. Thus, mini-PNL terminology is used 
for the PNL procedures done through 22–14 Fr-tract size 
(Turk et al. 2015). On the other hand, length of mini PNL 
instruments may not be long as to reach to desired calyx 
or to allow manipulations in the kidney, in obese patients. 
To the best of our knowledge, no previous study specifi-
cally investigated the safety or efficacy of mini-PNL in 
obese subjects. In this study, we aimed to compare the 
safety and efficacy of mini-PNL procedure between non-
obese and obese patients.
Methods
One hundred and eighty-two mini-PNL procedures were 
performed between May 2013 and January 2015 and 
their results were evaluated retrospectively. The patients 
were divided into two groups according to their BMI val-
ues. Patients with a BMI value lower than 30 kg/m2 were 
defined as the non-obese group, and those with a BMI 
of ≥30 kg/m2 were defined as the obese group. Patients 
were evaluated pre-operatively with urinalysis, urine 
culture, blood counts, intravenous pyelography (IVP) 
and computed tomography (CT). Appropriate antibiot-
ics were prescribed to patients with positive urine cul-
tures until a sterile urine culture was obtained. Patients 
younger than 18  years of age and patients with coagu-
lopathy were excluded from our study. The groups were 
compared according to their pre-operative demographic 
values and intraoperative and post-operative results. 
Patients with radio-opaque stones and non-radio-opaque 
stones were evaluated with kidney-ureter-bladder (KUB) 
X-ray and/or ultrasonography on post-operative day 2, 
respectively and all patients were evaluated regarding 
success rate with kidney-ureter-bladder (KUB) X-ray and 
ultrasonography or CT on the first post-operative month. 
Patients with complete stone clearance and patients with 
residual fragments under 4  mm were accepted as stone 
free.
Mini‑PNL technique
Under general anesthesia in the lithotomy position, a 5-Fr 
ureteral catheter was inserted and fixed to the 16-Fr blad-
der catheter. The calyceal system was visualized using 
contrast media in the prone position. Access was per-
formed using an 18-G percutaneous access needle under 
the fluoroscopy. A 0.035-inch hydrophilic guidewire was 
inserted, and a second guidewire was inserted with a dual 
lumen catheter. Dilatation was performed using Amplatz 
dilatators up to 18Fr. After placement Amplatz sheath to 
the collecting system over the dilator, nephroscopy was 
done with 12 or 17 Fr nephroscope (Karl Storz, Tuttlin-
gen, Germany) and stone fragmentation was performed 
using a laser, pneumatic or ultrasonic lithotripter. Stone 
extraction was performed using a 5-Fr stone extrac-
tion device. The surgery was finalized after insertion of a 
14-Fr nephrostomy tube under fluoroscopy.
Statistical analysis
The variables were expressed as numbers, percentage, 
mean values, and standard deviations. Comparisons 
were performed by Chi square test, Student t test, and 
Mann–Whitney U test. The significance of the relation-
ships between the variables was analyzed using Pearson 
correlation analysis.
Results
Pre-operative demographic values are shown in Table 1. 
The non-obese group consisted of 133 and the obese 
group consisted of 49 patients. The subjects in the non-
obese group were younger (p  <  0.001). Average stone 
size was similar between the groups (23.9 ±  9  mm and 
26.2  ±  8.6 in the non-obese and obese groups, respec-
tively, p  =  0.13). There was no significant difference 
between two groups in creatinine values, stone locations, 
operation side, hydronephrosis grade, opacity of stones, 
and history of operations and SWL.
Intra-operative findings of groups were summarized 
in Table  2. There was no statistical difference between 
two groups in operation time, fluoroscopy time, number 
of accesses, and access sites. Mean operation time was 
111 min in the non-obese group and 109 min in the obese 
group (p  =  0.805). Stone-free rates were 70.7  % in the 
non-obese group and 71.4 % in the obese group (p = 0.9). 
There was no significant difference in length of hospital 
stay, hemoglobin drop, or post-operative complications 
(Table 3). Body mass index was not correlated with any of 
the study variables (Table 4).
Discussion
Obesity appears to be a serious health problem in mul-
tiple ways and its incidence is significantly rising in the 
last 50 years. Risk of renal stone disease is high in obese 
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patients due to hyperinsulinemia related acidic urine 
and disordered ammonium metabolism and disorders of 
renal tubules (Asplin 2009; Sakhaee and Maalouf 2008).
Shock wave lithotripsy, F-URS, open surgery, PNL and 
mini-PNL are treatment options for renal stone disease. 
SWL is not a reasonable option in obese patients due to 
increased skin-to-stone distance, inability to maintain a 
clear vision during fluoroscopy, and technical difficulties 
in positioning of the patient (Robert et al. 1999; Munoz 
et al. 2003; Alkan et al. 2015). Open surgery is not rou-
tinely preferred due to increased risk of surgery site 
infections, post-operative pain, thromboembolism, and 
respiratory problems; prolonged healing time; and longer 
incision and scar formation (Choban and Flancbaum 
1997).
Recently, F-URS is an outstanding treatment method 
due to its natural orifice transluminal endoscopic surgery 
(NOTES) feature. F-URS has been shown to be effective 
in treatment of kidney stones, which are less than 2 cm 
but operation time is longer and multiple operations may 
be needed needed for complete stone clearance (Nguyen 
and Belis 1998; Sergeyev et  al. 2007). These problems 
limit the usage of F-URS in obese patients because pro-
longed operation times and multiple procedures can 
increase the risk of morbidity and mortality in these sub-
jects (Oberg and Poulsen 1996; Adams and Murphy 2000; 
Bond 1993; Postlethwait and Johnson 1972; Perberton 
and Manax 1971).
Notably, PNL is a preferable method in the treatment 
of renal stone disease in obese patients compared with 
Table 1 Comparison of pre-operative values
BMI Body Mass Index
Body Mass Index p values
<30 ≥30
% %
Number of patients 133 49
Sex 0.004
 Male 91 68.4 22 44.9
 Female 42 31.6 27 55.1
Mean age (years) 41.8 ± 12.6 (18–78) 51.7 ± 12.5 (19–76) <0.001
Mean Body Mass Index (kg/m2) 25.5 ± 4.3 (17.8–29.8) 34.3 ± 4.3 (30.0–46.4) <0.001
Mean stone size (mm) 23.9 ± 9.0 (5–60) 26.2 ± 8.6 (15–60) 0.134
Localization of stones
 Multiple calyces 67 50.4 27 55.1
 Pelvis 25 18.8 8 16.3
 Lower calyces 29 21.8 12 24.5
 Middle calyces 7 5.3 0 0
 Upper calyces 5 3.8 2 4.1
Side of the operated kidney
 Left 72 54.1 30 61.2
 Right 61 45.9 19 38.8
Grade of hydronephrosis 0.802
 0 4 3 1 2.1
 1 76 57.6 31 64.6
 2 44 33.3 15 31.3
 3 7 5.3 1 2.1
 4 1 0.8 0 0
Opacity 0.050
 Non-opaque 3 2.3 4 8.2
 Opaque 129 97 43 87.8
 Semi-opaque 1 0.8 2 4.1
Previous ESWL history 29 23.6 17 37.0 0.082
Previous PNL history 46 37.1 20 46.5 0.277
Previous open surgery history 26 21 8 17.8 0.648
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other treatment modalities. But it is clear that there are 
certain difficulties of the PNL procedure, especially in 
obese patients. Difficulty of positioning of the patient 
in the prone position, increased risk of pressure ulcer 
formation, and the potential need of increased rates of 
transfusion can be listed as some of these difficulties.
Mini-PNL, which was first defined for pediatric popu-
lation by Helal et  al. (1997), is a new treatment option 
for obese patients, with its lower risk of parenchymal 
injury and smaller tract size. There are no prior stud-
ies in literature about safety and efficacy of mini-PNL 
in obese patients. In a CROES study published by Fuller 
et  al. (2012), conventional PNL was performed in 5803 
patients who were stratified into 4 different groups 
according to their BMIs. Stone-free rates were 78.9 % in 
the obese group and 65.6 % in the morbid obese group. 
In a different study about efficacy of F-URS in obese 
patients published by Sari et  al. (2013), stone-free rates 
were 73.6 % in obese and 61.5 % in morbid obese group. 
In a similar study about efficacy of F-URS in obese 
patients with stones greater than 2  cm published by 
Alkan et al. (2015), stone-free rates were 75.6 % in obese 
and 66.6 % in morbid obese patients. In a similar study by 
Carson et al. (1988), 44 obese and 226 non-obese patients 
Table 2 Comparison of intra-operative values




Number of patients 133 49
Mean operation time (minutes) 111.4 ± 42.5 (45–250) 109.6 ± 41.6 (40–240) 0.805
Mean fluoroscopy time (minutes) 5.4 ± 3.4 (0.7–18.8) 5.8 ± 4.7 (0.8–20) 0.471
Number of access 0.415
 1 123 92.5 43 87.8
 2 9 6.8 6 12.2
 3 1 0.8 0 0
Access site 0.486
 Multiple 7 5.4 4 8.2
 Lower calyces 105 78.9 41 83.7
 Middle calyces 17 12.8 3 6.1
 Upper calyces 4 0.8 1 2.0
Table 3 Comparison of post-operative values




Number of patients 133 49
Mean hospitalization duration (hours) 65.7 ± 28.8 (24–192) 61.3 ± 47.1 (24–192) 0.454
Mean hemoglobin drop (g/dl) 0.78 ± 1.12 (0–4.8) 1.08 ± 1.2 (0–4.2) 0.139
Post-operative complications
 Fever 1 0.8 1 2.0 0.459
 Transfusion 4 3.0 1 2.0 0.723
 Angioembolisation 1 0.8 0 0 0.543
 Pulmonary complications 0 0
 Post-operative DJ insertion 24 18 6 12.2 0.350
Results 0.921
 Number of patients with residual stones 39 29.3 14 28.6
 Number patients with stone-free status 94 70.7 35 71.4
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were compared and no statistical difference was identi-
fied in operation times, the need for multiple procedures 
to achieve complete clearance, total length of hospital 
stay, complication rates, or stone-free rates. In our study, 
stone-free rates were 70.7 % in the non-obese group and 
71.4 % in the obese group.
In a CROES study about conventional PNL by Fuller 
et  al. (2012), complication rates in obese and morbid 
obese patients were 18.5 and 22.1  %, respectively. In a 
study by Simsek et al. (2014), conventional PNL was per-
formed in 2012 patients and these patients were stratified 
into 4 groups according to their BMIs. 370 patients had 
a BMI value greater than 30  kg/m2. 20 patients (5.4  %) 
developed pelvicalyceal perforation, 5 patients had pul-
monary problems (1.3  %), 2 patients developed cardiac 
problems (0.5  %), and 1 patient experienced hemor-
rhage, which required nephrectomy (0.2 %). In our study, 
the complication rate was 12.2 % in the obese group and 
pelvicalyceal perforation was seen in 4 patients (2.1  %). 
There were no pulmonary complications or hemorrhage 
requiring nephrectomy.
Bleeding is a frequent complication of PNL and man-
agement of bleeding is crucial. According to studies 
that have included large patient series, bleeding which 
requires transfusion can be seen in 5–18  % of cases 
and bleeding which requires embolization can be seen 
in 0.3–1  % (Michel et  al. 2007; Skolarikos and de la 
Rosette 2008; Kessaris et al. 1995; Turna et al. 2007; El-
Nahas et  al. 2007). Imaging modality during percuta-
neous access (ultrasonography vs. fluoroscopy), tract 
dilatation technique, tract size, and tract length are all 
factors, which can affect bleeding rates in PNL (Pearle 
et  al. 1998). In the light of this information, mini-PNL 
seems to be a preferable option due to its lesser paren-
chymal injury formation. In a study by Ates et al. (2011), 
evaluated the safety of PNL on 194 patients and bleed-
ing rates in obese and non-obese patients were 12.3 and 
12.9  %, respectively. In the CROES study, conventional 
PNL was performed in patients and bleeding rates in 
obese and morbid obese patients were 4.5 and 5.2  %, 
respectively (Fuller et al. 2012). In our study, mean hemo-
globin drop in the non-obese and obese groups were 
0.78 and 1.08  mg/dl, respectively. The rates of transfu-
sion requirements were similarly low in the two groups. 
Transfusion rates and bleeding rates in our study were 
lower when compared to conventional PNL data in the 
literature.
Our study has several limitations, including the ret-
rospective design of the study, presence of multiple 
surgeons instead of a single surgeon, absence of stone 
analysis results and evaluation of stone-free status. It is 
well known that KUB and ultrasonography are not as 
sensitive as computed tomography in the detection of 
residual stone fragments, especially in obese subjects. 
Although CT examination would provide a more accu-
rate success rate in obese subjects, the stone-free status 
was assessed with KUB and ultrasonography due to con-
cerns about the radiation exposure.
Conclusions
Our study has demonstrated that efficacy and safety of 
the mini-PNL procedure were similar in obese and non-
obese groups. Mini-PNL procedure seems to be a safe 
and efficacious option in obese patients with appropriate 
sized stones.
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Table 4 Summary of  univariate and  multivariate anaylsis, 
which shows the effect of obesity on operation outcomes
BMI Body Mass Index
BMI p values
Mean operation time (min) 0.805 0.486
Mean fluoroscopy time (min) 0.471 0.635
Mean hospitalization duration (h) 0.454 0.782
Mean hemoglobin drop (g/dl) 0.139 0.043
Post-operative complications
 Fever 0.462 0.638
 Transfusion 0.725 0.955
 Angioembolisation 0.545 0.473
 Post-operative DJ insertion 0.352 0.917
Result 0.922 0.54
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